Home LiteratureArticle Details
PMID: 16314856 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Neuroprotection associated with alternative splicing of NMDA receptors in rat cortical neurons.

British journal of pharmacology ·Vol. 147 ·No. 6 ·2006-03-00 ·Pages 622-33

Jaekel B, Mühlberg K, Garcia de Arriba S, Reichenbach A, Verdaguer E, Pallas M, Camins A, Nörenberg W, Allgaier C

Abstract

Exposure of cultured cortical neurons to elevated extracellular K(+) concentrations (25 mM) induces membrane depolarization and an increase in action-potential firing. Long-term high K(+) treatment was associated with an increased neuronal cell death. In surviving neurons, multiple changes occurred in the proportion of individual NMDA receptor subunit 1 (NR1) splice variant mRNA expression, whereas the overall expression of NR1, NR2A and NR2B transcripts remained unaffected. The high K(+)-induced changes in NR1 splice variant expression were virtually abolished upon a concurrent administration of tetrodotoxin (TTX; 3 microM). In voltage-clamp recordings performed on neurons resistant to high K(+) treatment, inward currents induced by NMDA (1-1,000 microM) were reduced. In K(+)-resistant cells, the activity of calpain but not of caspase-3 was diminished compared with controls kept in regular medium. NR function as well as calpain activity was not affected in cultures concomitantly treated with high K(+) and either TTX or a NR antagonist (CGS19755 (selfotel) or memantine). In conclusion, the present data indicate adaptive changes in NR1 splice variant expression and a decrease in NR function upon a sustained increase in neurotransmission. Accordingly, alternative splicing could be an endogenous mechanism to counteract cellular damage due to overactivation of excitatory NRs and may be associated with an impairment of necrotic mechanisms.

MeSH Terms
Action Potentials Alternative Splicing Animals Calpain/metabolism Cell Survival Cells, Cultured Cerebral Cortex/drug effects,embryology,metabolism,pathology Gene Expression Regulation Neurons/drug effects,metabolism,pathology Neuroprotective Agents/pharmacology Pipecolic Acids/pharmacology Potassium/toxicity RNA, Messenger/metabolism Rats Rats, Wistar Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors,genetics,metabolism Spectrin/metabolism Tetrodotoxin/pharmacology Time Factors
Chemicals
NR1A NMDA receptor, rat Neuroprotective Agents Pipecolic Acids RNA, Messenger Receptors, N-Methyl-D-Aspartate Spectrin Tetrodotoxin selfotel Calpain Potassium
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Jaekel Beate
Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Härtelstrabe 16-18, D-04107 Leipzig, Germany.
Mühlberg Katja
Garcia de Arriba Susana
Reichenbach Andreas
Verdaguer Ester
Pallas Mercè
Camins Antoni
Nörenberg Wolfgang
Allgaier Clemens
References (43)
43 references, click to expand
  1. Increased ambient glutamate concentration alters the expression of NMDA receptor subunits in cerebellar granule neurons.
    Neurochem Int. 2001 Aug;39(2):151-60 PMID: 11408094
  2. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
    J Pharmacol Exp Ther. 1988 Jul;246(1):65-75 PMID: 2899170
  3. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.
    Mol Pharmacol. 1994 May;45(5):846-53 PMID: 8190101
  4. Developmental aspects of NMDA receptor function.
    Crit Rev Neurobiol. 1998;12(3):177-204 PMID: 9847054
  5. The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region.
    Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6031-6 PMID: 8650214
  6. NMDA receptor subunits: diversity, development and disease.
    Curr Opin Neurobiol. 2001 Jun;11(3):327-35 PMID: 11399431
  7. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
    Lancet Neurol. 2002 Oct;1(6):383-6 PMID: 12849400
  8. The glutamate receptor ion channels.
    Pharmacol Rev. 1999 Mar;51(1):7-61 PMID: 10049997
  9. Synaptic activity-dependent developmental regulation of NMDA receptor subunit expression in cultured neocortical neurons.
    J Neurochem. 2000 Oct;75(4):1590-9 PMID: 10987840
  10. Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit.
    Mol Pharmacol. 1998 Mar;53(3):429-37 PMID: 9495808
  11. NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones.
    Br J Pharmacol. 1999 Jan;126(1):121-30 PMID: 10051128
  12. Synaptic targeting of N-methyl-D-aspartate receptor splice variants is regulated differentially by receptor activity.
    Neuroscience. 2005;131(1):99-111 PMID: 15680695
  13. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor.
    Nature. 1997 Jan 30;385(6615):439-42 PMID: 9009191
  14. NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex.
    J Neurosci. 1997 Apr 1;17(7):2469-76 PMID: 9065507
  15. MAP2 is localized to the dendrites of hippocampal neurons which develop in culture.
    Brain Res. 1984 Apr;315(2):314-8 PMID: 6722593
  16. Neuroprotection and neurodegenerative disease.
    J Clin Neurosci. 2002 Jan;9(1):4-8 PMID: 11749009
  17. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA.
    J Neurosci. 1994 May;14(5 Pt 2):3180-94 PMID: 8182465
  18. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments.
    J Neurosci. 1998 Jan 15;18(2):720-30 PMID: 9425014
  19. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).
    Neuropharmacology. 1993 Dec;32(12):1337-50 PMID: 8152525
  20. Ethanol tolerance and synaptic plasticity.
    Trends Pharmacol Sci. 1998 Dec;19(12):491-5 PMID: 9871410
  21. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.
    Mol Med. 2000 Jan;6(1):50-9 PMID: 10803408
  22. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
    Neuron. 1994 Mar;12(3):529-40 PMID: 7512349
  23. Changes in NMDA receptor subunit expression in response to contusive spinal cord injury.
    J Neurochem. 2000 Jul;75(1):174-84 PMID: 10854260
  24. The calpains in aging and aging-related diseases.
    Ageing Res Rev. 2003 Oct;2(4):407-18 PMID: 14522243
  25. Differential expression of alternatively spliced isoforms of neuronal nitric oxide synthase (nNOS) and N-methyl-D-aspartate receptors (NMDAR) in knockout mice deficient in nNOS alpha (nNOS alpha(Delta/Delta) mice).
    Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):13-23 PMID: 11146102
  26. Reduction of K+ uptake in glia prevents long-term depression maintenance and causes epileptiform activity.
    J Neurosci. 1997 Apr 15;17(8):2813-24 PMID: 9092603
  27. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit.
    Neuron. 1997 Mar;18(3):493-503 PMID: 9115742
  28. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
    Cerebrovasc Dis. 2004;17 Suppl 1:153-66 PMID: 14694293
  29. Trichloroethanol impairs NMDA receptor function in rat mesencephalic and cortical neurones.
    Eur J Pharmacol. 1999 Feb 5;366(2-3):R1-2 PMID: 10082216
  30. Microtubule-associated protein 2 and tubulin are differently distributed in the dendrites of developing neurons.
    Neuroscience. 1986 Feb;17(2):371-89 PMID: 3517689
  31. Ethanol sensitivity of NMDA receptors.
    Neurochem Int. 2002 Dec;41(6):377-82 PMID: 12213224
  32. The changing landscape of ischaemic brain injury mechanisms.
    Nature. 1999 Jun 24;399(6738 Suppl):A7-14 PMID: 10392575
  33. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines.
    Science. 1995 May 12;268(5212):873-6 PMID: 7754371
  34. Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits.
    Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5117-22 PMID: 15044697
  35. Proteolysis of NR2B by calpain in the hippocampus of epileptic rats.
    Neuroreport. 2005 Mar 15;16(4):393-6 PMID: 15729144
  36. Calcium-dependent inactivation of synaptic NMDA receptors in hippocampal neurons.
    J Neurophysiol. 1995 Jan;73(1):427-30 PMID: 7714587
  37. Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation.
    Eur J Neurosci. 2003 Sep;18(5):1197-205 PMID: 12956718
  38. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor.
    Science. 1995 Sep 22;269(5231):1734-7 PMID: 7569904
  39. Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death.
    Biol Chem. 2002 May;383(5):785-91 PMID: 12108543
  40. The calpain system.
    Physiol Rev. 2003 Jul;83(3):731-801 PMID: 12843408
  41. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit.
    Cell. 1996 Mar 8;84(5):745-55 PMID: 8625412
  42. Alternatively spliced isoforms of the NMDARI receptor subunit.
    Trends Neurosci. 1995 Jul;18(7):306-13 PMID: 7571011
  43. Glutamate in CNS disorders as a target for drug development: an update.
    Drug News Perspect. 1998 Nov;11(9):523-69 PMID: 15616669
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
2006-03-00
Pages
622-33
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1751340
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com